ClassID:

94041

C07D205/02 - CPC Classification

Classification description:

Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings

Sub-classes:
Recent Application in this class:
#1
20260055062
2026-02-26

HETEROCYCLIC INHIBITORS OF MCT4

#2
20230338341
2023-10-26

SUBSTITUTED 1H-IMIDAZO[4,5-b]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS

#3
20230000833
2023-01-05

Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulators

#4
20220251047
2022-08-11

HETEROCYCLIC INHIBITORS OF MCT4

#5
20220204460
2022-06-30

FXR (NR1H4) modulating compounds

#6
20210069155
2021-03-11

Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulators

#7
20200369632
2020-11-26

FXR (NR1H4) modulating compounds

#8
20200071282
2020-03-05

FXR (NR1H4) modulating compounds

#9
20190112275
2019-04-18

Heterocyclic inhibitors of MCT4

#10
20180162822
2018-06-14

Heterocyclic inhibitors of MCT4

#11
20180125826
2018-05-10

Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GluN2B receptor modulators

#12
20170355685
2017-12-14

FXR (NR1H4) modulating compounds

#13
20170029375
2017-02-02

Process of making adamantanamides

#14
20120053222
2012-03-01

Novel Metabolic Disease Therapy

#15
20110251164
2011-10-13

Carboxamide derivatives as muscarinic receptor antagonists

#16
20100168079
2010-07-01

Biaryl Benzylamine Derivatives

#17
20100029720
2010-02-04

Carboxamide derivatives as muscarinic receptor antagonists

#18
20090258901
2009-10-15

Ligands for monoamine receptors and transporters, and methods of use thereof

#19
20070105831
2007-05-10

Carboxamide derivatives as muscarinic receptor antagonists

#20
20050080078
2005-04-14

Method of treating addiction or dependence using a ligand for a monamine receptor or transporter